Peltomaa M - Search Results

1

Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.

Panelius J, Lahdenne P, Heikkilä T, Peltomaa M, Oksi J, Seppälä I. Panelius J, et al. Among authors: peltomaa m. J Med Microbiol. 2002 Sep;51(9):731-739. doi: 10.1099/0022-1317-51-9-731. J Med Microbiol. 2002. PMID: 12358063

2

Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis.

Heikkilä T, Seppälä I, Saxén H, Panelius J, Peltomaa M, Julin T, Carlsson SA, Lahdenne P. Heikkilä T, et al. Among authors: peltomaa m. J Clin Microbiol. 2002 Apr;40(4):1174-80. doi: 10.1128/JCM.40.4.1174-1180.2002. J Clin Microbiol. 2002. PMID: 11923327 Free PMC article.

3

Lyme borreliosis and facial paralysis--a prospective analysis of risk factors and outcome.

Peltomaa M, Pyykkö I, Seppälä I, Viljanen M. Peltomaa M, et al. Am J Otolaryngol. 2002 May-Jun;23(3):125-32. doi: 10.1053/ajot.2002.123434. Am J Otolaryngol. 2002. PMID: 12019479

4

Cloning of the gene encoding the decorin-binding protein B (DbpB) in Borrelia burgdorferi sensu lato and characterisation of the antibody responses to DbpB in Lyme borreliosis.

Heikkilä T, Seppälä I, Saxen H, Panelius J, Peltomaa M, Huppertz HI, Lahdenne P. Heikkilä T, et al. Among authors: peltomaa m. J Med Microbiol. 2002 Aug;51(8):641-648. doi: 10.1099/0022-1317-51-8-641. J Med Microbiol. 2002. PMID: 12171294

5

Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens.

Lahdenne P, Panelius J, Saxen H, Heikkilä T, Sillanpää H, Peltomaa M, Arnez M, Huppertz HI, Seppälä IJT. Lahdenne P, et al. Among authors: peltomaa m. J Med Microbiol. 2003 Jul;52(Pt 7):563-567. doi: 10.1099/jmm.0.05095-0. J Med Microbiol. 2003. PMID: 12808077

6

Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.

Panelius J, Lahdenne P, Saxén H, Carlsson SA, Heikkilä T, Peltomaa M, Lauhio A, Seppälä I. Panelius J, et al. Among authors: peltomaa m. J Neurol. 2003 Nov;250(11):1318-27. doi: 10.1007/s00415-003-0205-2. J Neurol. 2003. PMID: 14648148

7

Immune responses to borrelial VlsE IR6 peptide variants.

Sillanpää H, Lahdenne P, Sarvas H, Arnez M, Steere A, Peltomaa M, Seppälä I. Sillanpää H, et al. Among authors: peltomaa m. Int J Med Microbiol. 2007 Feb;297(1):45-52. doi: 10.1016/j.ijmm.2006.09.001. Epub 2007 Jan 17. Int J Med Microbiol. 2007. PMID: 17234451

8

Prevalence of granulocytic Ehrlichia and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected from Southwestern Finland and from Vormsi Island in Estonia.

Mäkinen J, Vuorinen I, Oksi J, Peltomaa M, He Q, Marjamäki M, Viljanen MK. Mäkinen J, et al. Among authors: peltomaa m. APMIS. 2003 Feb;111(2):355-62. doi: 10.1034/j.1600-0463.2003.1110209.x. APMIS. 2003. PMID: 12716393

9

The expanding clinical spectrum of ocular lyme borreliosis.

Mikkilä HO, Seppälä IJ, Viljanen MK, Peltomaa MP, Karma A. Mikkilä HO, et al. Among authors: peltomaa mp. Ophthalmology. 2000 Mar;107(3):581-7. doi: 10.1016/s0161-6420(99)00128-1. Ophthalmology. 2000. PMID: 10711899

10

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.

Oksi J, Nikoskelainen J, Hiekkanen H, Lauhio A, Peltomaa M, Pitkäranta A, Nyman D, Granlund H, Carlsson SA, Seppälä I, Valtonen V, Viljanen M. Oksi J, et al. Among authors: peltomaa m. Eur J Clin Microbiol Infect Dis. 2007 Aug;26(8):571-81. doi: 10.1007/s10096-007-0340-2. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17587070 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page